72 related articles for article (PubMed ID: 6282375)
1. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
Ukena D; Daly JW; Kirk KL; Jacobson KA
Life Sci; 1986 Mar; 38(9):797-807. PubMed ID: 3005794
[TBL] [Abstract][Full Text] [Related]
2. The P2X1 receptor and platelet function.
Mahaut-Smith MP; Jones S; Evans RJ
Purinergic Signal; 2011 Sep; 7(3):341-56. PubMed ID: 21484087
[TBL] [Abstract][Full Text] [Related]
3. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
4. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.
Jarvis GE; Humphries RG; Robertson MJ; Leff P
Br J Pharmacol; 2000 Jan; 129(2):275-82. PubMed ID: 10694233
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
Park HS; Hourani SM
Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
[TBL] [Abstract][Full Text] [Related]
6. P2 receptor subtypes in the cardiovascular system.
Kunapuli SP; Daniel JL
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):513-23. PubMed ID: 9841859
[TBL] [Abstract][Full Text] [Related]
7. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
Jin J; Kunapuli SP
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8070-4. PubMed ID: 9653141
[TBL] [Abstract][Full Text] [Related]
8. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
Pintor J; Díaz-Rey MA; Miras-Portugal MT
Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
[TBL] [Abstract][Full Text] [Related]
9. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
10. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G; Mills DC
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
[TBL] [Abstract][Full Text] [Related]
11. Nomenclature and classification of purinoceptors.
Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M
Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164
[No Abstract] [Full Text] [Related]
12. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder.
Burnstock G; Cusack NJ; Meldrum LA
Br J Pharmacol; 1984 Jun; 82(2):369-74. PubMed ID: 6733363
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
16. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
18. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
